GlassScriptPhysician profile
Felix G Rabito
NPI 1619939410
$41,375.27
in general payments reported to CMS, 2019-2025
55 companies · $3,701 in 2025
The $3,701 reported for 2025 was more than what 89% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,878 · 2020: $3,648 · 2021: $10K · 2022: $5,107 · 2023: $7,315 · 2024: $9,309 · 2025: $3,701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Honoraria: $9,200 · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,004.52 |
| Honoraria | $9,200.00 |
| Education | $120.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $21,938.77 | 2019-2025 | Sucraid, Sucraid |
| Abbvie INC. | $4,863.50 | 2019-2025 | |
| Janssen Biotech, INC. | $2,022.49 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,856.16 | 2019-2025 | Xifaxan, Relistor, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $1,340.43 | 2019-2025 | Entyvio, Eohilia |
| Gilead Sciences, INC. | $1,277.98 | 2019-2025 | |
| Celgene Corporation | $1,189.04 | 2021-2024 | Zeposia |
| Intercept Pharmaceuticals, INC. | $631.71 | 2019-2025 | Ocaliva |
| Pfizer INC. | $534.90 | 2019-2025 | |
| Ardelyx, INC. | $515.83 | 2022-2025 | Ibsrela |
| Genzyme Corporation | $488.08 | 2022-2025 | |
| Celltrion USA INC. | $313.02 | 2024-2025 | Vegzelma, Zymfentra |
| Ipsen Biopharmaceuticals, INC | $301.80 | 2024-2025 | Iqirvo |
| Lilly USA, LLC | $294.57 | 2024-2025 | Omvoh |
| Romark Laboratories, Lc | $293.17 | 2019-2020 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $278.33 | 2019-2024 | Captivator II |
| Phathom Pharmaceuticals, INC. | $272.33 | 2024-2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $231.87 | 2021-2023 | Zeposia |
| Janssen Scientific Affairs, LLC | $215.75 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $202.48 | 2019-2024 | Dificid |
| Evoke Pharma, INC. | $179.07 | 2022-2025 | Gimoti |
| Ferring Pharmaceuticals INC. | $168.53 | 2019-2023 | Rebyota |
| Braintree Laboratories, INC. | $156.43 | 2019-2025 | Sutab, Suflave |
| Enterra Medical, INC. | $153.15 | 2022 | |
| Ironwood Pharmaceuticals, INC | $140.00 | 2022-2025 | Linzess |
| Conmed Corporation | $131.70 | 2021 | |
| Redhill Biopharma INC. | $126.89 | 2020-2023 | Talicia, Movantik, Aemcolo |
| Aimmune Therapeutics, INC. | $107.53 | 2025 | Zenpep, Vowst |
| Shionogi INC | $106.95 | 2019 | |
| Novo Nordisk INC | $95.15 | 2022-2025 | Wegovy |
| Daiichi Sankyo INC. | $87.24 | 2020-2024 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $76.72 | 2025 | Dupixent |
| Micro-Tech Endoscopy USA, INC. | $76.43 | 2024-2025 | Lockado |
| Echosens North America, INC. | $74.27 | 2019-2024 | Fibroscan |
| Organon LLC | $72.52 | 2023-2024 | Hadlima |
| Alfasigma USA, INC. | $65.67 | 2020-2022 | |
| Intra-Sana Laboratories | $49.71 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Biocon Biologics INC | $48.76 | 2024-2025 | Yesintek, Hulio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.99 | 2023 | Cyltezo |
| Pentax of America, INC. | $39.68 | 2022 | |
| Ucb, INC. | $33.26 | 2019 | |
| Allergan, INC. | $32.66 | 2019-2020 | |
| Medtronic, INC. | $29.75 | 2022-2023 | Bravo |
| Endo Pharmaceuticals INC. | $28.34 | 2020 | |
| Pharmacosmos Therapeutics INC. | $26.87 | 2021 | |
| Madrigal Pharmaceuticals | $25.06 | 2025 | Rezdiffra |
| Amgen INC. | $22.80 | 2023 | Amjevita, Avsola |
| Capsovision, INC. | $19.96 | 2023 | Capsocam Plus |
| Axonics, INC. | $18.47 | 2021 | |
| Alexion Pharmaceuticals, INC. | $16.96 | 2020 | |
| Steris Corporation | $16.79 | 2020 | |
| Fresenius Kabi USA, LLC | $15.48 | 2023 | Idacio |
| Cumberland Pharmaceuticals, INC. | $13.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $10.48 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$20,648.97 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felix Rabito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.